Antibody Response to Pneumococcal Vaccines PPV and PCV in Beta Thalassemia Major without Splee
Phase 2
- Conditions
- Beta Thalassemia Major.Beta thalassaemia
- Registration Number
- IRCT201110116660N3
- Lead Sponsor
- Mazandaran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Inclusion Criteria: Splenectomized Thalassemia Major Patients who have not received Pneumococcal Vaccine or have received it more than 5 years ago. Exclusions Criteria: Tthalassemia Major with Spleen.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Antibody response to pneumococcal vaccines ppv. Timepoint: Evaluation of IgG eight weeks after vaccination. Method of measurement: Laboratory Test.;Antibody response to pneumococcal vaccines pcv. Timepoint: Evaluation of IgG three months after vaccination. Method of measurement: Laboratory Test.
- Secondary Outcome Measures
Name Time Method Along Diseases. Timepoint: After of study. Method of measurement: Laboratory Test.